Amber Technology's Reference Center

Pau D Arco:

http://www.umm.edu/altmed/ConsHerbs/PaudArcoch.html

Pau d'arco, or the inner bark of the Tabebuia avellanedae tree, is native to Brazil, where it is used traditionally to treat a wide range of conditions including pain, arthritis, inflammation of the prostate gland (prostatitis), fever, dysentery, boils and ulcers, and various cancers. Preliminary laboratory research examining the properties of pau d'arco is beginning to suggest that the traditional uses may have scientific merit. Such laboratory studies have shown that pau d'arco has pain killing, diuretic, anti-inflammatory, anti-infectious, anti-psoriatic, and anti-cancer abilities. Taking this early data, combined with information collected about traditional uses, herbalists may recommend pau d'arco to treat or prevent a number of conditions, including candidiasis (a yeast infection of the vaginal or oral areas), herpes simplex virus, influenza, parasitic diseases such as schistosomiasis, bacterial infections such as brucellosis, and inflammation of the cervix (cervicitis) or the vagina (vaginitis). Pau d'arco may also reduce inflammation of the joints associated with arthritis.

Supporting Research

Anesini C, Perez C. Screening of plants used in Argentine folk medicine for antimicrobial activity. J Ethnopharmacol. 1993;39:119–128.

Colman de Saizarbitoria T, Anderson JE, Alfonso D, McLaughlin JL.Bioactive furonaphtoquinones from Tabebuia barbata (Bignoniaceae). Acta Cient Venez. 1997;48(1):42-46.

Dinnen RD, Ebisuzaki K. The search for novel anticancer agents: a differentiation-based assay and analysis of a folklore product. Anticancer Res. 1997;(2A):1027–1033.

Kinghorn AD, Balandrin MA, eds. American Chemical Symposium Series. Human Medicinal Agents from Plants. Washington, DC: American Chemical Society; 1992:16–17.

Miranda FG, Vilar JC, Alves IA, Cavalcanti SC, Antoniolli AR. Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract. BMC Pharmacol. 2001;1(1):6.

Muller K, Sellmer A, Wiegrebe W. Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth. J Nat Prod. 1999;62(8):1134-1136.

Pinto CN, Dantas AP, De Moura KC, et al. Chemical reactivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacy. Arzneimittelforschung. 2000;50(12):1120-1128.

Pizzorno JE, Murray MT. Textbook of Natural Medicine. New York: Churchill Livingstone; 1999:967-974.

Portillo A, Vila R, Freixa B, Adzet T, Canigueral S. Antifungal activity of Paraguayan plants used in traditional medicine. J Ethnopharmacol .2001;76(1):93-98.

Robbers JE, Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press; 1999:246-247.

Ueda S, Umemura T, Dohguchi K, et al. Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures. Phytochemistry. 1994;36:323–325.